Creative Medical Technology Holdings Reports Positive Data on ImmCelz™ Immunotherapy Product
PHOENIX, Oct. 12, 2021 /PRNewswire/ — (OTC-CELZ) Creative Medical Technology Holdings Inc. announced today proof of concept data demonstrating the ability of its next generation ImmCelz™ immunotherapy product to “reprogram” patient immune cells using the Company’s patent pending “ex vivo…
Comments Off on Creative Medical Technology Holdings Reports Positive Data on ImmCelz™ Immunotherapy Product